Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects

Journal of Law, Medicine and Ethics 37 (2):209-221 (2009)
  Copy   BIBTEX

Abstract

This manuscript addresses how developing countries can maximize access to essential medicines and minimize unwanted side-effects within the legal environment of a compulsory license regime. While compulsory licensing can play a role in improving public health, external social and political conditions must be considered in order to make licensing an effective practice

Categories

Keywords

Reprint years

DOI

10.1111/j.1748-720x.2009.00366.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,168

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Access to essential medicines: A Hobbesian social contract approach.Richard E. Ashcroft - 2005 - Developing World Bioethics 5 (2):121–141.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.
Improving access to essential medicines: How health concerns can be prioritised in the global governance system.Devi Sridhar - 2008 - Public Health Ethics 1 (2):83-88.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.
Rationing the access to high cost medicines in developing countries.Debora Diniz - 2009 - Developing World Bioethics 9 (2):ii-iii.
Incentivizing access and innovation for essential medicines: A survey of the problem and proposed solutions.Michael Ravvin - 2008 - Public Health Ethics 1 (2):110-123.
Microsoft, refusal to license intellectual property rights, and the incentives balance test of the EU commission.Wolfgang Kerber & Claudia Schmidt - unknown
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.
Race against time: The export of essential medicines to rwanda.Matthew Rimmer - 2008 - Public Health Ethics 1 (2):89-103.
Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation.Rudolf V. Van Puymbroeck - 2010 - Journal of Law, Medicine and Ethics 38 (3):520-549.
The dilemma of intellectual property rights for pharmaceuticals: The tension between ensuring access of the poor to medicines and committing to international agreements.Jillian Clare Cohen & Patricia Illingworth - 2003 - Developing World Bioethics 3 (1):27–48.

Analytics

Added to PP
2010-09-13

Downloads
41 (#389,665)

6 months
4 (#796,002)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Pharmaceutical Innovation: Law & the Public's Health.Kevin Outterson - 2009 - Journal of Law, Medicine and Ethics 37 (2):173-175.

Add more citations

References found in this work

No references found.

Add more references